Open-access journal that reports health science discoveries linking research to clinical applications for human health.
Histoplasmosis misdiagnosed as malignancies in immunocompetent and immunocompromised patients: A global perspective on clinical presentation, radiological and pathological findings https://lnkd.in/eDiYVMqc
Effect of Noninvasive Airway Management of Comatose Patients With Acute Poisoning: A Randomized Clinical Trial https://buff.ly/3Iq41cC
Corporate communication | Master's in Social Innovation | Diversity, equity & inclusion advocate | Education | Content Creator | Digital Marketing | Storytelling | Change Management
Navigate with confidence with a motion-compensated, real-time view of the coronary arteries. All while protecting patients at risk of AKI and CIN. 📌Learn more: https://lnkd.in/eifWdYg3 * Demonstrated in a multi-center, randomized clinical trial. Hennessey B, et al., Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial. EuroIntervention. 2024 Feb 5;20(3):e198-e206.
#TheSundayRead! 📖 Comparison of Clinical and Radiological Outcomes Between Different (Balloon) Guide Catheter With and Without Inflated Balloon in Acute Ischemic #Stroke Patients: A MaSQ-Registry Study https://lnkd.in/dmQNmmqH #OpenAccess 🔓
Collaborating with Healthcare Senior Leadership to bring Innovate Solutions to Critical Healthcare Challenges
Navigate with confidence with a motion-compensated, real-time view of the coronary arteries. All while protecting patients at risk of AKI and CIN. Learn more: https://lnkd.in/eaSRCmmz * Demonstrated in a multi-center, randomized clinical trial. Hennessey B, et al., Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial. EuroIntervention. 2024 Feb 5;20(3):e198-e206.
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients
Navigate with confidence with a motion-compensated, real-time view of the coronary arteries. All while protecting patients at risk of AKI and CIN. Learn more: https://lnkd.in/gccRFtbJ * Demonstrated in a multi-center, randomized clinical trial. Hennessey B, et al., Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial. EuroIntervention. 2024 Feb 5;20(3):e198-e206.
This Thursday brings another intriguing edition of Health & Technology Findings. The first article is from the FDA which has approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months of age and older. https://lnkd.in/eH63UdNn The next article examines a new sunscreen formula that protects against both UV light and heat from the sun using radiative cooling. https://lnkd.in/gh49gDAb The last article is about scientists that were part of a collaborative effort to discover an effective treatment for lung fibrosis and found the best candidate may be one that is already available as a cough medicine around the world, dextromethorphan. https://lnkd.in/gfDicQqk #manhattanlife #healthandtechnologyfindings #healthandtechnology #healthresearch #medicalresearch
#HeartFailure2024 The consistency of the treatment benefit of remote hemodynamic monitoring in chronic heart failure: a predefined subgroup analysis of the randomised clinical Trial MONITOR-HF
#HeartFailure2024 The consistency of the treatment benefit of remote hemodynamic monitoring in chronic heart failure: a predefined subgroup analysis of the randomised clinical Trial MONITOR-HF
Navigate with confidence with a motion-compensated, real-time view of the coronary arteries. All while protecting patients at risk of AKI and CIN. Learn more: https://lnkd.in/gdcid6BM * Demonstrated in a multi-center, randomized clinical trial. Hennessey B, et al., Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial. EuroIntervention. 2024 Feb 5;20(3):e198-e206.